Unum plans NASDAQ IPO

Immuno-oncology company Unum Therapeutics Inc. (Cambridge, Mass.) filed on March 2 to raise up to $86.3 million in an IPO on NASDAQ underwritten

Read the full 230 word article

User Sign In